These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

881 related items for PubMed ID: 25518184

  • 1. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
    Boonya-ussadorn T, Choi WH, Hyun J, Kim SH, Chung SK, Yoo IeR.
    J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184
    [Abstract] [Full Text] [Related]

  • 2. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA, Reitan BC, Biermann M, Trovik J, Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB, Haldorsen IS.
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [Abstract] [Full Text] [Related]

  • 3. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
    Konuralp Atakul B, Taşkın S, Soydal Ç, Sükür YE, Kahraman A, Koyuncu K, İbiş E, Ortac F.
    Gynecol Obstet Invest; 2017 Aug; 82(4):340-348. PubMed ID: 27771729
    [Abstract] [Full Text] [Related]

  • 4. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
    Kim HJ, Cho A, Yun M, Kim YT, Kang WJ.
    Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
    [Abstract] [Full Text] [Related]

  • 5. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
    Signorelli M, Guerra L, Buda A, Picchio M, Mangili G, Dell'Anna T, Sironi S, Messa C.
    Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
    [Abstract] [Full Text] [Related]

  • 6. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
    Fasmer KE, Gulati A, Dybvik JA, Ytre-Hauge S, Salvesen Ø, Trovik J, Krakstad C, Haldorsen IS.
    Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
    [Abstract] [Full Text] [Related]

  • 7. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF.
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [Abstract] [Full Text] [Related]

  • 8. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.
    Crivellaro C, Signorelli M, Guerra L, De Ponti E, Pirovano C, Fruscio R, Elisei F, Montanelli L, Buda A, Messa C.
    Gynecol Oncol; 2013 Aug; 130(2):306-11. PubMed ID: 23707673
    [Abstract] [Full Text] [Related]

  • 9. FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer.
    Sudo S, Hattori N, Manabe O, Kato F, Mimura R, Magota K, Sugimori H, Hirata K, Sakuragi N, Tamaki N.
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):676-84. PubMed ID: 25504022
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
    Hahn S, Hecktor J, Grabellus F, Hartung V, Pöppel T, Kimmig R, Forsting M, Antoch G, Heusner TA.
    Acta Radiol; 2012 Jun 01; 53(5):518-23. PubMed ID: 22547387
    [Abstract] [Full Text] [Related]

  • 11. Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer.
    Lee HJ, Ahn BC, Hong CM, Song BI, Kim HW, Kang S, Jeong SY, Lee SW, Lee J.
    Nuklearmedizin; 2011 Jun 01; 50(5):204-13. PubMed ID: 21727990
    [Abstract] [Full Text] [Related]

  • 12. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU, Won KS, Song BI, Jeong WK, Baek SK, Kim HW.
    Cancer Imaging; 2018 Sep 14; 18(1):32. PubMed ID: 30217167
    [Abstract] [Full Text] [Related]

  • 13. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
    Park JY, Lee JJ, Choi HJ, Song IH, Sung CO, Kim HO, Chae SY, Kim YT, Nam JH.
    Ann Surg Oncol; 2017 Aug 14; 24(8):2303-2310. PubMed ID: 28550488
    [Abstract] [Full Text] [Related]

  • 14. The clinical value of 18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography for predicting regional lymph node metastasis and non-curative surgery in primary gastric carcinoma.
    Choi JY, Shim KN, Kim SE, Jung HK, Jung SA, Yoo K.
    Korean J Gastroenterol; 2014 Dec 14; 64(6):340-7. PubMed ID: 25530585
    [Abstract] [Full Text] [Related]

  • 15. Prediction of Pathologic Grade and Prognosis in Mucoepidermoid Carcinoma of the Lung Using ¹⁸F-FDG PET/CT.
    Park B, Kim HK, Choi YS, Kim J, Zo JI, Choi JY, Shim YM.
    Korean J Radiol; 2015 Dec 14; 16(4):929-35. PubMed ID: 26175595
    [Abstract] [Full Text] [Related]

  • 16. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K.
    Scand J Urol Nephrol; 2011 Mar 14; 45(2):122-8. PubMed ID: 21231796
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT.
    Wang Y, Ma S, Dong M, Yao Y, Liu K, Zhou J.
    BMC Pulm Med; 2015 Mar 08; 15():20. PubMed ID: 25880540
    [Abstract] [Full Text] [Related]

  • 18. Value of metabolic parameters of primary lesions examined by 18F-FDG PET/CT for endometrial cancer in preoperative evaluation.
    Gai QZ, Lv YB, Li GY, Zhang DQ, Gao Z, Fang XH.
    Eur Rev Med Pharmacol Sci; 2021 Mar 08; 25(6):2493-2502. PubMed ID: 33829435
    [Abstract] [Full Text] [Related]

  • 19. 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
    Song BI, Lee SW, Jeong SY, Chae YS, Lee WK, Ahn BC, Lee J.
    J Nucl Med; 2012 Sep 08; 53(9):1337-44. PubMed ID: 22870824
    [Abstract] [Full Text] [Related]

  • 20. Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.
    van Nijnatten TJA, Goorts B, Vöö S, de Boer M, Kooreman LFS, Heuts EM, Wildberger JE, Mottaghy FM, Lobbes MBI, Smidt ML.
    Eur J Nucl Med Mol Imaging; 2018 Feb 08; 45(2):179-186. PubMed ID: 28905091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.